Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Baumann

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Current Drug Metabolism|January 29, 2008
Effect of the NMDA-receptor antagonist dextromethorphan in infant rat pneumococcal meningitisJohann Sellner, Ralph Ringer, Pierre Baumann, et al.
Forensic Science International|March 12, 2004
Death following acute poisoning by moclobemideChristian Giroud, Beat Horisberger, Chin Eap, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 15, 2002
Carbamazepine augmentation in depressive patients non-responding to citalopram: a pharmacokinetic and clinical pilot studyLina Steinacher, Pierre Vandel, Daniele F Zullino, et al.
Drug and Alcohol Dependence|March 1, 2003
Cytochrome P4503A4 metabolic activity, methadone blood concentrations, and methadone dosesMarc Shinderman, Sarz Maxwell, Marlyse Brawand-Amey, et al.
Journal of Psychopharmacology (Oxford, England)|December 8, 2004
Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspectsElio Ciusani, Daniele F Zullino, Chin B Eap, et al.
Chirality|April 23, 2002
Disposition of venlafaxine enantiomers in rats with hepatic encephalopathy after chronic drug treatmentCecilia Wikell, Chin B Eap, Martin Josefsson, et al.
Drug Safety|September 2, 2006
Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilanceEveline Jaquenoud Sirot, Jan Willem van der Velden, Katharina Rentsch, et al.
Pharmacogenetics|January 25, 2003
Role of CYP2D6 in the stereoselective disposition of venlafaxine in humansChin B Eap, Etienne Lessard, Pierre Baumann, et al.
Revue Medicale Suisse|September 7, 2017
Pierre Baumann, Ursula Amstutz, Roland P Bühlmann, et al.
Therapeutic Drug Monitoring|September 26, 2003
Routine therapeutic drug monitoring in patients treated with 10-360 mg/day citalopramYves Le Bloc'h, Brigitte Woggon, Hansjörg Weissenrieder, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Current Drug Metabolism|January 29, 2008
Effect of the NMDA-receptor antagonist dextromethorphan in infant rat pneumococcal meningitisJohann Sellner, Ralph Ringer, Pierre Baumann, et al.
Forensic Science International|March 12, 2004
Death following acute poisoning by moclobemideChristian Giroud, Beat Horisberger, Chin Eap, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 15, 2002
Carbamazepine augmentation in depressive patients non-responding to citalopram: a pharmacokinetic and clinical pilot studyLina Steinacher, Pierre Vandel, Daniele F Zullino, et al.
Drug and Alcohol Dependence|March 1, 2003
Cytochrome P4503A4 metabolic activity, methadone blood concentrations, and methadone dosesMarc Shinderman, Sarz Maxwell, Marlyse Brawand-Amey, et al.
Journal of Psychopharmacology (Oxford, England)|December 8, 2004
Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspectsElio Ciusani, Daniele F Zullino, Chin B Eap, et al.
Chirality|April 23, 2002
Disposition of venlafaxine enantiomers in rats with hepatic encephalopathy after chronic drug treatmentCecilia Wikell, Chin B Eap, Martin Josefsson, et al.
Drug Safety|September 2, 2006
Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilanceEveline Jaquenoud Sirot, Jan Willem van der Velden, Katharina Rentsch, et al.
Pharmacogenetics|January 25, 2003
Role of CYP2D6 in the stereoselective disposition of venlafaxine in humansChin B Eap, Etienne Lessard, Pierre Baumann, et al.
Revue Medicale Suisse|September 7, 2017
Pierre Baumann, Ursula Amstutz, Roland P Bühlmann, et al.
Therapeutic Drug Monitoring|September 26, 2003
Routine therapeutic drug monitoring in patients treated with 10-360 mg/day citalopramYves Le Bloc'h, Brigitte Woggon, Hansjörg Weissenrieder, et al.
Pageof 10